Literature DB >> 11484845

Modulation induced by estradiol in the acute phase of Trypanosoma cruzi infection in mice.

E M de Souza1, M T Rivera, T C Araújo-Jorge, S L de Castro.   

Abstract

We investigated the effect of 17beta-estradiol on mice resistant to infection by Trypanosoma cruzi. Infected Balb/C, C3H and C57BL/6 female mice had a longer survival time than males, C57BL/6 showing the highest difference (50% cumulative mortality in females versus 100% in males). This lineage was treated with estradiol (from 0.05 microg to 500 microg/mouse) 1 day before infection. Treatment with 50 microg or 500 microg estradiol/ mouse increased mortality and parasitaemia. Low doses had no effect or tended to reduce both parameters. Given that estradiol presented no in vitro effect on trypomastigotes or epimastigotes, the involvement of a direct hormonal effect on the parasite is improbable. Alterations in the humoral T. cruzi-specific response were also discarded, since the kinetics and concentration of anti-T. cruzi IgG were not affected by the treatment. Females infected during an estradiol-descending phase (meta-oestrus) survived longer than those infected during other phases of the oestrous cycle. We confirmed that estradiol interferes with T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11484845     DOI: 10.1007/s004360100376

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  14 in total

1.  Advances in imaging of animal models of Chagas disease.

Authors:  Linda A Jelicks; Herbert B Tanowitz
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

2.  Experimental infection of Calomys callosus with atypical strains of Toxoplasma gondii shows gender differences in severity of infection.

Authors:  Priscila Silva Franco; Mayara Ribeiro; Janice Buiate Lopes-Maria; Lourenço Faria Costa; Deise Aparecida Oliveira Silva; Bellisa de Freitas Barbosa; Angelica de Oliveira Gomes; José Roberto Mineo; Eloisa Amália Vieira Ferro
Journal:  Parasitol Res       Date:  2014-04-30       Impact factor: 2.289

3.  In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.

Authors:  Maria de Nazaré Correia Soeiro; Elen Mello de Souza; Cristiane França da Silva; Denise da Gama Jaen Batista; Marcos Meuser Batista; Beatriz Philot Pavão; Julianna Siciliano Araújo; Claudia Alessandra Fortes Aiub; Patrícia Bernardino da Silva; Jessica Lionel; Constança Britto; Kwangho Kim; Gary Sulikowski; Tatiana Y Hargrove; Michael R Waterman; Galina I Lepesheva
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

4.  Different Therapeutic Outcomes of Benznidazole and VNI Treatments in Different Genders in Mouse Experimental Models of Trypanosoma cruzi Infection.

Authors:  F H Guedes-da-Silva; D G J Batista; C F da Silva; M B Meuser; M R Simões-Silva; J S de Araújo; C G Ferreira; O C Moreira; C Britto; G I Lepesheva; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

5.  Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.

Authors:  Ana Paula Galvão Da Silva; Jacqueline F Jacysyn; Ises De Almeida Abrahamsohn
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

6.  Sex steroids effects on the molting process of the helminth human parasite Trichinella spiralis.

Authors:  Romel Hernández-Bello; Ricardo Ramirez-Nieto; Saé Muñiz-Hernández; Karen Nava-Castro; Lenin Pavón; Ana Gabriela Sánchez-Acosta; Jorge Morales-Montor
Journal:  J Biomed Biotechnol       Date:  2011-11-03

Review 7.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

8.  4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.

Authors:  Claudia Magalhaes Calvet; Jun Yong Choi; Diane Thomas; Brian Suzuki; Ken Hirata; Sharon Lostracco-Johnson; Liliane Batista de Mesquita; Alanderson Nogueira; Marcelo Meuser-Batista; Tatiana Araujo Silva; Jair Lage Siqueira-Neto; William R Roush; Mirian Claudia de Souza Pereira; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2017-12-27

9.  Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.

Authors:  Alejandro F Benatar; Gabriela A García; Jacqeline Bua; Juan P Cerliani; Miriam Postan; Laura M Tasso; Jorge Scaglione; Juan C Stupirski; Marta A Toscano; Gabriel A Rabinovich; Karina A Gómez
Journal:  PLoS Negl Trop Dis       Date:  2015-10-09

10.  Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

Authors:  Augusto E Bivona; Andrés Sánchez Alberti; Marina N Matos; Natacha Cerny; Alejandro C Cardoso; Celina Morales; Germán González; Silvia I Cazorla; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.